RICHARD MARQUEZ: Open Payments
NPI 1306877766 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 14 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $339 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $244 |
| Globus Medical, Inc. | 2 | $159 |
| Amgen Inc. | 2 | $139 |
| Novo Nordisk Inc | 1 | $123 |
| PFIZER INC. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: BREZTRI, Senza, EVENITY, Ozempic, PAXLOVID, ENTRESTO, AIRSUPRA, FARXIGA.
Industry payments across TX — which companies pay providers there.
